Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ICL Group Ltd. Board/Management Information 2015

Sep 3, 2015

6843_ffr_2015-09-03_a33efbe4-e9f6-457a-a316-8fdd1560e776.zip

Board/Management Information

Open in viewer

Opens in your device viewer

6-K 1 dp59352_6k.htm FORM 6-K

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September, 2015

Commission File Number: 001-13742

ISRAEL CHEMICALS LTD.

(Exact name of registrant as specified in its charter)

Israel Chemicals Ltd.

Millennium Tower

23 Aranha Street

P.O. Box 20245

Tel Aviv, 61202 Israel

(972-3) 684-4400

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F X Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes No X

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes No X

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

ISRAEL CHEMICALS LTD.

  1. Immediate Report regarding End of Tenure of Directors Mr. Yair Orgler and Mr. Victor Medina.

Field: Page; Sequence: 2

Field: /Page

Item 1

September 3, 2015

End of Tenure of Directors Mr. Yair Orgler and Mr. Victor Medina

The Company hereby wishes to report that the tenures of Mr. Yair Orgler and of Mr. Victor Medina as members of the Company's Board of Directors will expire on September 4, 2015. Mr. Orgler and Mr. Medina served as members of the Company's Board since September 5, 2006.

The Board of Directors wishes to thanks Mr. Orgler and Mr. Medina for their long standing contribution to the Company and to its achievements.

Field: Page; Sequence: 3

Field: /Page

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

/s/ Kobi Altman
Name: Kobi Altman
Title: Executive Vice President and Chief Financial Officer
/s/ Lisa Haimovitz
Name: Lisa Haimovitz
Title: Vice President, General Counsel and Corporate Secretary

Date: September 3, 2015

Field: Page; Sequence: 4; Options: Last

Field: /Page